• Keine Ergebnisse gefunden

Reactions 1871, p199 - 4 Sep 2021

N/A
N/A
Protected

Academic year: 2022

Aktie "Reactions 1871, p199 - 4 Sep 2021"

Copied!
1
0
0

Wird geladen.... (Jetzt Volltext ansehen)

Volltext

(1)

Reactions 1871, p199 - 4 Sep 2021

Hydroxychloroquine

S

QTc interval prolonged following off label use: case report

In a retrospective study conducted in southern India hospital involving healthcare workers, who received prophylactic hydroxychloroquine between June 2020 to July 2020, a patient [age and sex not stated] was described, who experienced prolongation of QTc interval following off label administration of hydroxychloroquine for prophylaxis against COVID-19 [route not stated].

The patient received off label treatment with prophylactic hydroxychloroquine at a dose of 400mg twice a day on day 1 followed by 400mg once a day every week with meal for COVID-19. The patient’s baseline QTc interval was normal before initiation of hydroxychloroquine. A follow-up ECG after administration of hydroxychloroquine demonstrated raised QTc interval [duration of treatment to reaction onset and outcome not stated].

Dixit PK, et al. Side effects of hydroxychloroquine prophylaxis against COVID-19 in healthcare workers. Medical Journal Armed Forces India 77 (Suppl. 2): S513-S514, Jul

2021. Available from: URL: http://doi.org/10.1016/j.mjafi.2020.11.016 803592145

1

Reactions 4 Sep 2021 No. 1871 0114-9954/21/1871-0001/$14.95 Adis © 2021 Springer Nature Switzerland AG. All rights reserved

Referenzen

ÄHNLICHE DOKUMENTE

Ten days later, he presented due to left-sided lower motor neuron facial weakness, initially House Brackmann grade III.. He was diagnosed with

An 80-year-old woman developed worsening of COVID-19 pneumonia following treatment with methylprednisolone and prednisone for relapsed ulcerative colitis (UC) [durations of

Case 3: The 60-year-old woman, who had family history of thrombosis and medical history of hyperlipidaemia, diabetes mellitus and hypertension, presented eight days after the

In a retrospective study of prospectively collected data within an ongoing, non-interventional, multicenter, observational cohort study (Italian PBC Registry) of 191 patients

A 72-year-old woman developed idiopathic thrombocytopenic purpura following administration of mRNA-1273 Covid-19 vaccine.. The woman received the first dose of the mRNA-1273

In a clinical chart review and post-mortem examination from a retrospective monocentric study (COVIDAge study) involving 264 patients aged 75 years and older and

Based on these findings, clinical presentation and after excluding other aetiologies, it was concluded that the haematochezia might have caused due to the ischaemic ulcerative

A 20-year-old woman developed COVID-19 respiratory infection and Mycobacterium tuberculosis infection during immunosuppressant drug therapy with dimethyl fumarate for